Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Paricalcitol Injection Extension Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism

NCT00701805 is registered in ClinicalTrials.gov with Abbott as lead sponsor.

NCT NCT00701805
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00701805 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Paricalcitol Injection Extension Long-term Safety Study of Paricalcitol Injection in Chronic Kidney Disease Subjects Receiving Hemodialysis With Secondary Hyperparathyroidism
Lead sponsor
Abbott
Phase
Phase 2
Overall status
Completed
Start date
July 31, 2008
Completion date
December 31, 2009
Enrollment
107 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

hemodialysis, secondary hyperparathyroidism